Shell may be on the verge of turning one of its grand downstream ambitions into a very public admission that the numbers no longer add up.
According to the Financial Times, Shell’s U.S. chemicals assets have attracted interest from potential bidders including ExxonMobil, LyondellBasell, Apollo and the chemicals arm of Kuwait Petroleum Corporation.
The assets could fetch as much as $8 billion, although the process remains preliminary and there is no guarantee that a transaction will take place.
Financial Times: Shell draws Exxon interest in $8bn US chemical assets sale
Investing.com: Shell’s chemicals exit draws interest from Exxon and LyondellBasell
Bloomberg has also reported on the interest being generated by Shell’s U.S. chemicals business.
Bloomberg: Shell’s U.S. chemicals unit draws interest from suitors
This is not a minor portfolio tidy-up.
It is potentially a retreat from a business into which Shell poured enormous amounts of capital and which it once presented as an important part of its integrated downstream future.
Four U.S. sites — and one enormous Pennsylvania bet
According to the FT report, the U.S. portfolio under consideration spans four sites in Louisiana, Texas and Pennsylvania, producing chemicals used in plastics, detergents, pharmaceuticals and numerous other products.
The most striking asset is Shell’s huge Monaca polymers complex in Pennsylvania.
The plant began operating in 2022 and is capable of producing up to 1.6 million tonnes of polymers a year.
Shell has reportedly invested around $14 billion in the facility.
Now consider the arithmetic.
The entire collection of U.S. chemicals assets might fetch as much as $8 billion.
That does not mean Monaca itself is being valued at a precise loss of $6 billion. The proposed package contains several assets, and construction expenditure cannot be compared simplistically with an eventual sale price.
But the contrast is nevertheless extraordinary.
Shell spent approximately $14 billion on one flagship complex, yet the whole U.S. portfolio now being marketed could reportedly be worth considerably less than that.
That is hardly the ending Shell envisaged when the Pennsylvania project was approved.
From flagship investment to possible exit
The Monaca plant was supposed to represent precisely the kind of integration that oil majors once liked to celebrate.
Cheap U.S. shale gas would provide abundant ethane feedstock.
The cracker would convert that feedstock into ethylene.
The downstream units would produce polyethylene pellets for plastics manufacturers.
Shell would therefore capture value further along the hydrocarbon chain rather than simply selling oil and gas.
On paper, it was a compelling industrial proposition.
In practice, Shell’s chemicals operation has struggled to produce the returns now demanded by chief executive Wael Sawan.
And that is where the story becomes much bigger than Monaca.
$45 billion of underperforming capital
The Financial Times reports that Sawan previously identified around $45 billion of capital tied up in businesses that were underperforming for Shell, principally chemicals and renewable energy.
That is an extraordinary sum.
It also helps explain the intensity of the portfolio surgery taking place under his leadership.
Sawan has made returns, cash generation and capital discipline central to his strategy.
Businesses that cannot compete for capital internally are being sold, reduced, partnered or closed.
Chemicals appears to have moved firmly into that category.
Earlier reporting said Shell did not regard itself as the “natural owner” of its chemicals portfolio and intended to reduce its exposure.
At its March 2025 strategy update, Shell said it would examine strategic and partnership opportunities for U.S. chemicals operations while considering high-grading and selective closures in Europe.
Investopedia: Shell plans to boost upstream and gas business and may sell chemicals assets
That language was already a clear warning.
Now the potential buyers appear to be arriving.
ExxonMobil circling Shell’s assets
Perhaps the most eye-catching name on the reported bidder list is ExxonMobil.
Shell and Exxon have spent well over a century competing against one another around the world.
Now Exxon is reportedly considering buying assets that Shell no longer wants.
There is considerable irony in that.
Shell chief executive Wael Sawan has spent much of his tenure trying to close the valuation gap between Shell and its larger American competitors, particularly ExxonMobil and Chevron.
His strategy has involved sharper cost control, higher shareholder distributions and renewed emphasis on oil, gas and LNG.
Now one of the very companies Shell is trying to resemble may be examining whether it can extract value from assets Shell is preparing to discard.
There could hardly be a more vivid illustration of Shell’s strategic transformation.
LyondellBasell provides another historical twist
LyondellBasell is another interesting potential buyer.
There is an historical connection.
Basell, one of LyondellBasell’s predecessor businesses, was once jointly owned by Royal Dutch Shell and BASF before being sold in 2005.
Basell subsequently acquired Lyondell Chemical and became LyondellBasell.
So part of Shell’s chemicals heritage ultimately helped produce one of the companies now reportedly considering buying Shell chemicals assets back out of the portfolio.
Corporate history occasionally develops a sense of humour all by itself.
Apollo and Kuwait Petroleum also interested
The FT also identifies private equity giant Apollo and the chemicals arm of state-owned Kuwait Petroleum Corporationamong those that have expressed interest.
According to the report, potential buyers submitted non-binding indicative offers in July.
Those approaches apparently include proposals for both the entire portfolio and individual pieces of it.
That means Shell may not simply sell the operation wholesale.
The outcome could be a break-up.
Some facilities could go to strategic buyers.
Others could end up in private-equity ownership.
Shell might retain selected pieces if bids fail to meet its expectations.
And there remains the possibility that no transaction takes place at all.
This is therefore a sale process, not a completed sale.
That distinction should be kept clear.
Shell does not want to sell cheaply
Sawan has previously indicated that Shell would be patient with chemicals because management did not want to dispose of assets at the bottom of the cycle.
That makes the timing particularly interesting.
For much of the recent period, the chemicals division struggled with weak margins.
The FT says the operation had been loss-making before stronger market conditions this year improved profitability.
If Shell proceeds now, management may believe the market has recovered sufficiently to produce acceptable bids.
Alternatively, it may have concluded that getting the capital out of chemicals is strategically more important than holding on in hope of a substantially better valuation.
Either interpretation says something important about Sawan’s priorities.
The European chemicals business may be next
The U.S. assets are not the whole story.
According to the latest reporting, Shell is also working with advisers to market European chemicals assets, although those are expected to command substantially less money.
Shell’s European chemicals footprint includes operations in countries such as Britain, Germany and the Netherlands.
Earlier reports suggested the review could encompass the Fife Natural Gas Liquids plant at Mossmorran in Scotland, as well as other major European facilities.
Wall Street Journal: Shell explores sale of chemicals assets in the U.S. and Europe
That raises the possibility that Shell is not merely pruning chemicals.
It may be fundamentally withdrawing from large parts of a business that once formed a significant component of the integrated Shell empire.
Another chapter in the Sawan revolution
Since becoming chief executive in January 2023, Wael Sawan has moved Shell decisively toward a narrower definition of what deserves capital.
The company has reduced or abandoned various renewable-energy ambitions, sold businesses, cut costs and concentrated increasingly on oil, integrated gas, LNG, trading and shareholder returns.
In March 2025, Shell announced plans to cut annual costs by billions of dollars, reduce capital expenditure and increase the proportion of operating cash flow returned to shareholders.
The objective was explicit: become more competitive with the American supermajors.
Financial Times: Shell slashes costs in drive to close valuation gap with U.S. rivals
The prospective chemicals sale fits that strategy perfectly.
But it also exposes the less flattering side of portfolio discipline.
Before management can boast about reallocating capital wisely, shareholders are entitled to examine why so much capital ended up in poorly performing businesses in the first place.
The uncomfortable question: who approved the billions?
The easy corporate story is:
Markets changed.
Chemicals margins weakened.
Shell reacted rationally.
Management is now protecting shareholders by selling assets whose returns are inadequate.
All of that may be true.
But it does not answer the historical question.
Who decided to commit such enormous capital to these businesses, and what assumptions justified those decisions?
Monaca is particularly difficult to ignore.
A project costing approximately $14 billion does not arrive by accident.
It requires years of forecasting, executive scrutiny, board-level capital allocation and assumptions extending decades into the future.
Only four years after entering production, Monaca is reportedly sitting inside a chemicals portfolio Shell may sell.
That is remarkably fast for an asset conceived as a multi-decade industrial investment.
Shareholders therefore have every right to ask what changed — and whether Shell’s original assumptions were ever robust enough.
Chemicals were supposed to be part of oil’s future
There is a wider strategic paradox here.
For years, the oil industry has argued that declining demand for petrol and diesel would not necessarily destroy long-term hydrocarbon demand because petrochemicals would consume an increasing proportion of oil and gas.
Plastics, synthetic materials, pharmaceuticals and industrial chemicals would become an important destination for hydrocarbons even as electric vehicles displaced transport fuels.
That underlying thesis has not disappeared.
Indeed, the FT points out that other oil companies and state energy groups are expanding in chemicals precisely because they want greater exposure to the full oil-to-products value chain.
Saudi Aramco and Abu Dhabi’s Adnoc have both pursued major chemicals investments.
So have other competitors.
That creates a fascinating contradiction.
If chemicals are part of the future of hydrocarbons, why is Shell trying to get out?
The answer may simply be that chemicals remain attractive — but Shell’s particular portfolio does not produce sufficiently attractive returns.
That is hardly reassuring to those who financed it.
Shell’s retreat from Singapore was an early warning
The prospective U.S. and European exits also follow Shell’s withdrawal from major downstream assets in Singapore.
Shell agreed to sell its Singapore Energy and Chemicals Park to a joint venture involving Chandra Asri and Glencore, another example of Sawan’s drive to simplify the portfolio and eliminate businesses unable to meet return expectations.
Seen individually, every disposal can be justified as portfolio optimisation.
Seen collectively, they represent something more dramatic.
The sprawling vertically integrated Royal Dutch Shell of old is being dismantled piece by piece.
The modern Shell increasingly wants to own only those portions of the value chain capable of producing superior financial returns.
Everything else must justify its existence.
Strategic discipline — or cleaning up yesterday’s mistakes?
There is nothing inherently wrong with selling an underperforming business.
Quite the opposite.
One of the worst mistakes corporate executives make is continuing to pour money into investments simply because enormous sums have already been spent.
If Shell can obtain an attractive price for assets that another owner can operate more profitably, selling them could be entirely sensible.
That is the charitable interpretation.
But investors should not confuse a sensible exit with proof that the original investment was sensible.
Those are different questions.
If Shell ultimately sells a chemicals portfolio at a large discount to the capital invested in it, management can legitimately claim credit for stopping further value destruction.
It cannot retroactively transform the original capital allocation into a triumph.
The environmental dimension should not disappear either
There is another issue.
Chemical plants do not vanish when Shell sells them.
They continue producing plastics and chemicals under somebody else’s ownership.
Their emissions continue.
Their environmental risks continue.
Their eventual decommissioning obligations continue.
A sale therefore reduces Shell’s portfolio exposure.
It does not necessarily reduce the physical environmental footprint of the industry.
That distinction is particularly relevant when divestments are presented as evidence of Shell becoming a lower-emissions company.
Selling an emitting asset reduces the seller’s reported emissions.
It does not automatically reduce global emissions.
The new owner may continue operating the same equipment.
This is accounting reality, not decarbonisation.
Deer Park carries its own environmental history
Shell’s Deer Park chemicals facility near Houston is among the U.S. assets previously reported as being under strategic review.
The plant has also had serious environmental and safety issues.
A major fire in 2023 burned for days, and the State of Texas subsequently sued Shell over alleged environmental damage arising from the incident.
Earlier reporting about the possible chemicals sale specifically noted Deer Park’s environmental and legal history.
Houston Chronicle: Shell reportedly considering sale of Deer Park chemicals plant
Any eventual transaction will therefore involve more than production capacity and cash flows.
Prospective buyers will also examine environmental liabilities, maintenance requirements, regulatory exposure and long-term capital needs.
What Shell says — and does not say
Shell has not announced that the reported sale is complete.
According to the Financial Times, Shell, ExxonMobil and Apollo declined to comment, while LyondellBasell and Kuwait Petroleum Corporation did not respond to requests for comment.
There is therefore no confirmed buyer, no confirmed transaction value and no guarantee that the process will result in a sale.
That qualification is essential.
What is established is the broader strategic direction.
Shell announced in 2025 that it wanted to reduce chemicals exposure and explore partnerships and other strategic options in the United States.
The latest reports suggest that process has now advanced far enough to attract indicative bids from some formidable names.
The possible $8 billion exit tells its own story
If no sale occurs, Shell will continue owning valuable industrial assets capable of generating earnings when chemicals markets improve.
If a sale does occur, the final price and structure will tell shareholders much more about how successful — or unsuccessful — Shell’s chemicals investment really was.
An $8 billion headline sounds enormous.
It is enormous.
But corporate numbers require context.
When one component of the portfolio alone absorbed roughly $14 billion of capital, an $8 billion valuation for the broader U.S. package does not look like a victory lap.
It looks like damage limitation.
From empire builder to portfolio pruner
There was a time when Royal Dutch Shell prided itself on breadth.
Exploration.
Production.
LNG.
Refining.
Chemicals.
Petrochemicals.
Power.
Renewables.
Trading.
Retail.
The integrated oil major supposedly captured value everywhere.
Wael Sawan is pursuing almost the opposite philosophy.
Own fewer things.
Demand more from them.
Dispose of the laggards.
Return more cash to shareholders.
And concentrate on the areas where Shell believes it genuinely possesses competitive advantage.
There is sound corporate logic behind that.
There is also an implicit verdict on some of the decisions made by previous generations of Shell management.
Chemicals appears increasingly to be one of them.
And there is one final irony
Shell is trying to make itself look more like ExxonMobil.
Now ExxonMobil is reportedly considering buying something Shell wants rid of.
If Exxon ultimately acquires part of the portfolio and proceeds to make attractive returns from it, the irony will become considerably sharper.
Perhaps Shell will prove correct and escape a structurally unattractive business at precisely the right time.
Perhaps bidders will prove that the assets were worth more under different ownership.
Perhaps the process will collapse and Shell will retain them.
We do not yet know.
But the market has already delivered one unmistakable message.
A collection of plants Shell once regarded as strategic industrial assets is now being examined by outsiders because Shell itself no longer appears convinced that it should own them.
After billions of dollars of investment, that alone is quite a retreat.
Sources
Financial Times — Shell draws Exxon interest in $8bn U.S. chemical assets sale
Bloomberg — Shell’s U.S. chemicals unit draws interest from suitors
Investing.com — Shell’s chemicals exit draws interest from Exxon and LyondellBasell
Wall Street Journal — Shell explores sale of chemicals assets in the U.S. and Europe
Investopedia — Shell plans to boost upstream and gas business and may sell chemicals assets
Financial Times — Shell slashes costs in drive to close valuation gap with U.S. rivals
Houston Chronicle — Shell reportedly considering sale of Deer Park chemicals plant
Site wide disclaimer also applies.
*This website and sisters royaldutchshellgroup.com, shellnazihistory.com, royaldutchshell.website, johndonovan.website, shellnews.net, and shellwikipedia.com, are owned by John Donovan - more information here. There is also a Wikipedia segment, the Shell DPA Files, "Shell and the Spies", the Shell Leaks files, the Independent Shell Archive, as well as books written and published by John Donovan - Kindle eBooks. Timeline of the Donovan Shell Feud. Toxic History of Royal Dutch Shell Group. Shell and the Donovans: The Full Media Record — 550+ Articles, 110 Books, 40 Years. *All conjured up by internet wizz, Nick Gill.
